Transcriptional reprogramming via signaling domains of CD2, CD28, and 4-1BB
Annika De Sousa Linhares(Medical University of Vienna), Judith Leitner(University of Vienna)
Cited by 2
Related Papers
Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
|Scientific Reports|2019|196
A Comprehensive and Quantitative Analysis of the Major Specificities in Rabbit Antithymocyte Globulin Preparations
|American Journal of Transplantation|2013|114
A T‐cell reporter platform for high‐throughput and reliable investigation of TCR function and biology
|Clinical & Translational Immunology|2020|28